Literature DB >> 24297653

Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma.

Kenji Fukushima1, Takumi Fukumoto, Kaori Kuramitsu, Masahiro Kido, Atsushi Takebe, Motofumi Tanaka, Tomoo Itoh, Yonson Ku.   

Abstract

BACKGROUND: Posthepatectomy liver failure (PHLF) is a major complication after hepatectomy. As there was no standardized definition, the International Study Group of Liver Surgery (ISGLS) defined PHLF as increased international normalized ratio and hyperbilirubinemia on or after postoperative day 5 in 2010. We evaluated the impact of the ISGLS definition of PHLF on hepatocellular carcinoma (HCC) patients.
METHODS: We retrospectively analyzed 210 consecutive HCC patients who underwent curative hepatectomy at our facility from 2005 to 2010. The median follow-up period after hepatectomy was 35.2 months.
RESULTS: Thirty-nine (18.6%) patients fulfilled the ISGLS definition of PHLF. Overall survival (OS) rates at 1, 3, and 5 years in patients with/without PHLF were 69.1/93.5, 45.1/72.5, and 45.1/57.8%, respectively (P = 0.002). Recurrence-free survival (RFS) rates at 1, 3, and 5 years in patients with/without PHLF were 40.9/65.9, 15.7/38.3, and 15.7/20.3%, respectively (P = 0.003). Multivariate analysis revealed that PHLF was significantly associated with both OS (P = 0.047) and RFS (P = 0.019). Extent of resection (P < 0.001), intraoperative blood loss (P = 0.002), and fibrosis stage (P = 0.040) were identified as independent risk factors for developing PHLF.
CONCLUSION: The ISGLS definition of PHLF was associated with OS and RFS in HCC patients, and long-term survival will be improved by reducing the incidence of PHLF.

Entities:  

Mesh:

Year:  2013        PMID: 24297653     DOI: 10.1007/s11605-013-2423-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

Review 1.  Posthepatectomy liver failure.

Authors:  Teresa Schreckenbach; Juliane Liese; Wolf O Bechstein; Christian Moench
Journal:  Dig Surg       Date:  2012-03-15       Impact factor: 2.588

Review 2.  Management of HCC.

Authors:  Carlos Rodríguez de Lope; Silvia Tremosini; Alejandro Forner; María Reig; Jordi Bruix
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

Review 3.  Liver regeneration.

Authors:  G K Michalopoulos; M C DeFrances
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

4.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

5.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

6.  Prognostic significance of postoperative complications after hepatectomy for hepatocellular carcinoma.

Authors:  Yukiyasu Okamura; Shin Takeda; Tsutomu Fujii; Hiroyuki Sugimoto; Shuji Nomoto; Akimasa Nakao
Journal:  J Surg Oncol       Date:  2011-06-28       Impact factor: 3.454

Review 7.  The role of signaling pathways in the development and treatment of hepatocellular carcinoma.

Authors:  S Whittaker; R Marais; A X Zhu
Journal:  Oncogene       Date:  2010-07-19       Impact factor: 9.867

8.  Reductive surgery plus percutaneous isolated hepatic perfusion for multiple advanced hepatocellular carcinoma.

Authors:  Yonson Ku; Takeshi Iwasaki; Masahiro Tominaga; Takumi Fukumoto; Tetsuya Takahashi; Masahiro Kido; Satoshi Ogata; Masanori Takahashi; Yoshikazu Kuroda; Shinichi Matsumoto; Hidefumi Obara
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

9.  Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.

Authors:  Takeaki Ishizawa; Kiyoshi Hasegawa; Taku Aoki; Michiro Takahashi; Yosuke Inoue; Keiji Sano; Hiroshi Imamura; Yasuhiko Sugawara; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Gastroenterology       Date:  2008-03-08       Impact factor: 22.682

10.  Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma.

Authors:  K S Chok; K K Ng; R T Poon; C M Lo; S T Fan
Journal:  Br J Surg       Date:  2009-01       Impact factor: 6.939

View more
  25 in total

1.  Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data.

Authors:  Hao Hu; Hong Han; Xi Kun Han; Wen Ping Wang; Hong Ding
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.

Authors:  Chuan Li; Xiao-Yun Zhang; Wei Peng; Tian-Fu Wen; Lu-Nan Yan; Bo Li; Jia-Yin Yang; Wen-Tao Wang; Ming-Qing Xu
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

3.  Liver failure after hepatocellular carcinoma surgery.

Authors:  Hiroaki Motoyama; Akira Kobayashi; Takahide Yokoyama; Akira Shimizu; Norihiko Furusawa; Hiroshi Sakai; Noriyuki Kitagawa; Yohei Ohkubo; Teruomi Tsukahara; Shin-ichi Miyagawa
Journal:  Langenbecks Arch Surg       Date:  2014-10-22       Impact factor: 3.445

4.  Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.

Authors:  Masato Fujiyoshi; Atsushi Kuno; Masanori Gotoh; Moto Fukai; Hideki Yokoo; Hirofumi Kamachi; Toshiya Kamiyama; Masaaki Korenaga; Masashi Mizokami; Hisashi Narimatsu; Akinobu Taketomi
Journal:  J Gastroenterol       Date:  2015-03-15       Impact factor: 7.527

5.  Liver Stiffness Assessed by Shear Wave Elastography Predicts Postoperative Liver Failure in Patients with Hepatocellular Carcinoma.

Authors:  Yinghao Shen; Chenhao Zhou; Guodong Zhu; Guoming Shi; Xiaodong Zhu; Cheng Huang; Jian Zhou; Jia Fan; Hong Ding; Ning Ren; Hui-Chuan Sun
Journal:  J Gastrointest Surg       Date:  2017-05-16       Impact factor: 3.452

6.  The Incidence of Posthepatectomy Liver Failure Defined by the International Study Group of Liver Surgery among Living Donors.

Authors:  Kaori Kuramitsu; Takumi Fukumoto; Tsuyoshi Kobayashi; Kenji Fukushima; Sho Okimoto; Takeshi Iwasaki; Masahiro Tominaga; Yoh Zen; Hideki Ohdan; Yonson Ku
Journal:  J Gastrointest Surg       Date:  2016-01-20       Impact factor: 3.452

7.  Surgical Management of Giant Hepatic Hemangioma: Single Center's Experience with 144 Patients.

Authors:  Mohamed Abdel Wahab; Ayman El Nakeeb; Mahmoud Abdelwahab Ali; Youssef Mahdy; Ahmed Shehta; Mohamed Abdulrazek; Mohamed El Desoky; Rihame Abdel Wahab
Journal:  J Gastrointest Surg       Date:  2018-02-27       Impact factor: 3.452

8.  Post-hepatectomy liver failure after hepatic resection for hepatocellular carcinoma: a single center experience.

Authors:  Ahmed Shehta; Ahmed Farouk; Amgad Fouad; Ahmed Aboelenin; Ahmed Nabieh Elghawalby; Rami Said; Mohamed Elshobary; Ayman El Nakeeb
Journal:  Langenbecks Arch Surg       Date:  2020-08-10       Impact factor: 3.445

Review 9.  The current role of laparoscopic resection for HCC: a systematic review of past ten years.

Authors:  Stefano Di Sandro; Maria Danieli; Fabio Ferla; Andrea Lauterio; Riccardo De Carlis; Laura Benuzzi; Vincenzo Buscemi; Isabella Pezzoli; Luciano De Carlis
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-18

10.  Posthepatectomy Liver Failure Affects Long-Term Function After Resection for Hepatocellular Carcinoma.

Authors:  Naohiko Nakamura; Etsuro Hatano; Kohta Iguchi; Satoru Seo; Kojiro Taura; Shinji Uemoto
Journal:  World J Surg       Date:  2016-04       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.